FMP

FMP

Enter

SLDB - Solid Bioscienc...

photo-url-https://financialmodelingprep.com/image-stock/SLDB.png

Solid Biosciences Inc.

SLDB

NASDAQ

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

5.82 USD

0.13 (2.23%)

About

ceo

Mr. Alexander G. Cumbo

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new ...

CIK

0001707502

ISIN

US83422E2046

CUSIP

83422E105

Address

141 Portland Street

Phone

617 337 4680

Country

US

Employee

88

IPO Date

Jan 26, 2018

SLDB Financial Summary

CIK

0001707502

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

83422E105

ISIN

US83422E2046

Country

US

Price

5.82

Beta

1.91

Volume Avg.

267.15k

Market Cap

224.62M

Shares

-

52-Week

2.0-15.05

DCF

2.4

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.77

P/B

-

Website

https://www.solidbio.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest SLDB News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep